Has Stacy Manning received payments from drug or device companies?

Yes. Drug and device makers reported $5,846 in general payments to Stacy Manning across 272 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stacy Manning did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stacy Manning come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stacy Manning

Family · Fresno, CANPI 1417193624

Payments from drug & device makers

$5,846in general payments, 2019–2025

Across 272 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$922
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$850
Alkermes, Inc.$634
Vanda Pharmaceuticals Inc.$582
AbbVie$571
Lundbeck LLC$425
plus $2K from 16 others

What the payments were for

Food & beverage$5,842100%
Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	48	$922
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	41	$850
Alkermes, Inc.	28	$634
Vanda Pharmaceuticals Inc.	19	$582
AbbVie	44	$571
Lundbeck LLC	18	$425
Axsome Therapeutics, Inc.	18	$409
Teva Pharmaceuticals USA, Inc.	13	$299
E.r. Squibb & Sons, L.L.C.	6	$295
Neurocrine Biosciences, Inc.	7	$220
Johnson & Johnson	7	$175
Supernus Pharmaceuticals, Inc.	7	$142
Sage Therapeutics, LLC	3	$62
Ironshore Pharmaceuticals Inc.	2	$48
Corium, LLC	2	$47
Collegium Pharmaceutical, Inc.	2	$45
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Tris Pharma Inc	1	$23
Azurity Pharmaceuticals, Inc.	1	$20
Indivior Inc.	1	$20
Paratek Pharmaceuticals, Inc.	1	$13
Incyte Corporation	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LYBALVI$520
CAPLYTA$250
Fanapt$235
INGREZZA$138
Auvelity$123
COBENFY$123
REXULTI$122
VRAYLAR$114

How this compares

$5,846 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	11	$2,326
Duloxetine Hcl	24	$584
Mirtazapine	12	$241
Escitalopram Oxalate	22	$183
Sertraline Hcl	23	$179
Lorazepam	14	$33

Paid to pharmacies, not to this prescriber.

Other family in Fresno

Freddy EspinozaFresno$33K
Lori RobertsonChino Hills$475K
Annette ShonLos Angeles$406K
Nancy GardettoSan Diego$394K
Lisa HigginsHanford$311K
Jennifer TougasBakersfield$302K
Kim SchaferSacramento$288K
Dawn MeyerSan Diego$270K
Jennifer KangCerritos$255K
Jenine StoneEscondido$231K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →